Accessibility Menu
Biote Stock Quote

Biote (NASDAQ: BTMD)

$2.63
(-5.4%)
-0.15
Price as of December 23, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$2.63
Daily Change
(-5.4%) $0.15
Day's Range
$2.56 - $2.78
Previous Close
$2.63
Open
$2.78
Beta
N/A
Volume
133,615
Average Volume
122,057
Market Cap
$85M
Market Cap / Employee
$2.63M
52wk Range
$2.32 - $6.36
Revenue
N/A
Gross Margin
0.71%
Dividend Yield
N/A
EPS
$0.79
CAPs Rating
N/A
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Biote Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BTMD-54.58%N/AN/A-74%
S&P+15.66%+86.6%+13.29%+65%
Advertisement

Biote Company Info

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.

News & Analysis

No results found

No news articles found for Biote.

Financial Health

General

Q3 2025YOY Change
Revenue$47.96M-6.7%
Gross Profit$33.67M-4.9%
Gross Margin70.20%1.3%
Market Cap$99.84M-45.1%
Market Cap / Employee$460.09K0.0%
Employees21711.9%
Net Income$9.22M-27.2%
EBITDA$9.64M-30.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$28.05M-26.6%
Accounts Receivable$7.97M-6.1%
Inventory17.6-12.1%

Liabilities

Q3 2025YOY Change
Long Term Debt$109.16M-5.5%
Short Term Debt$37.71M460.1%

Ratios

Q3 2025YOY Change
Return On Assets27.09%19.1%
Return On Invested Capital38.94%-10.5%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$13.57M-3.1%
Operating Free Cash Flow$14.07M-9.5%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Earnings34.315.454.453.78-86.26%
Price to Book-1.48-0.99-1.41-1.12-16.12%
Price to Sales1.170.620.640.56-39.63%
Price to Tangible Book Value-1.31-0.87-1.21-0.96-19.29%
Price to Free Cash Flow TTM6.763.893.903.37-44.88%
Enterprise Value to EBITDA32.9023.5121.4724.5026.10%
Free Cash Flow Yield14.8%25.7%25.6%29.7%81.43%
Total Debt$179.74M$179.32M$153.67M$146.87M20.08%

No results found

No podcast episodes available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.